Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

The Lancet Oncology

Volumn 10, Issue 1, 2009, Pages 35-43

  Mazzaferro, Vincenzo ^a   Llovet, Josep M ^b,g   Miceli, Rosalba ^a   Bhoori, Sherrie ^a   Schiavo, Marcello ^a   Mariani, Luigi ^a   Camerini, Tiziana ^a   Roayaie, Sasan ^b   Schwartz, Myron E ^b   Grazi, Gian Luca ^c   Adam, René ^d   Neuhaus, Peter ^e   Salizzoni, Mauro ^f   Bruix, Jordi ^g   Forner, Alejandro ^g   De Carlis, Luciano ^h   Cillo, Umberto ⁱ   Burroughs, Andrew K ^j   Troisi, Roberto ^k   Rossi, Massimo ^l   Gerunda, Giorgio E ^m   Lerut, Jan ⁿ   Belghiti, Jacques ^o   Boin, Ilka ^p   Gugenheim, Jean ^q   Rochling, Fedja ^r   Van Hoek, Bart ^s   Majno, Pietro ^t   more..

^a NATIONAL CANCER INSTITUTE   (Italy)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d HÔPITAL PAUL BROUSSE   (France)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f MOLINETTE HOSPITAL   (Italy)

^g HOSPITAL CLÍNIC   (Spain)

^h OSPEDALE NIGUARDA CA GRANDA   (Italy)

ⁱ UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^j ROYAL FREE HOSPITAL   (United Kingdom)

^k GHENT UNIVERSITY HOSPITAL   (Belgium)

^l SAPIENZA UNIVERSITY OF ROME   (Italy)

^m UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

ⁿ CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^o BEAUJON HOSPITAL   (France)

^p University Hospital of Campinas   (Brazil)

^q CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^r NEBRASKA MEDICAL CENTER   (United States)

^s LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^t GENEVA UNIVERSITY HOSPITALS   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CADAVER DONOR; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; EXPLORATORY RESEARCH; GRAFT SURVIVAL; HUMAN; INTERNET; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; TREATMENT OUTCOME; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHILD; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 57749191711     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(08)70284-5     Document Type: Article

References (40)

1. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. New Engl J Med 334 (1996) 693-699
2. Bismuth H., Chiche L., Adam R., et al. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 218 (1993) 145-151
3. Llovet J.M., Brú C., and Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19 (1999) 329-338
4. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
5. AJCC. Cancer staging handbook. TNM liver classification. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). American Joint Committee (AJCC) on cancer staging manual. 6th edn. (2002), Springer-Verlag, New York 131-144
6. Yoo H.Y., Patt C.H., Geschwind J.F., et al. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol 2 (2003) 4265-4267
7. Majno P., and Mazzaferro V. Living donor liver transplantation for hepatocellular carcinoma exceeding conventional criteria: questions, answers and demands for a common language. Liver Transpl 12 (2006) 896-898
8. Llovet J.M., Schwartz M., and Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 25 (2005) 181-200
9. Schwartz M., Roayaie S., and Konstadoulakis M. Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol 4 (2007) 424-432
10. Yao F.Y., Ferrell L., Bass N.M., et al. Liver transplantation for HCC: expansion of the tumor size limits does not adversely impact survival. Hepatology 33 (2001) 1394-1403
11. Llovet J.M., Fuster J., Bruix J., and for the BCLC Group. Intention to treat analysis for surgical treatment of hepatocellular carcinoma: resection vs transplantation. Hepatology 30 (1999) 1434-1440
12. Consensus conference: indications for liver transplantation, January 19 and 20, 2005, Lyon-Palais Des Congrès: text of recommendations (long version). Liver Transpl 12 (2006) 998-1011
13. Llovet J.M., Di Bisceglie A.M., Bruix J., et al. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100 (2008) 698-711
14. Harrell Jr. F.E., Lee K.L., and Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15 (1996) 361-387
15. Durrleman S., and Simon R. Flexible regression models with cubic splines. Stat Med 8 (1989) 551-561
16. Akaike H. Information theory and an extension of the Maximum Likelihood principle. In: Patrov B.N., and Csaki F. (Eds). Proceedings of the 2nd International Symposium on Information Theory (1973), Akademia Kiedo, Budapest
17. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 69 (1982) 239-241
18. Efron B., and Tibshirani R.J. An introduction to the bootstrap (1993), Chapman and Hall, New York
19. Copas J.B. Regression, prediction and shrinkage. J R Statist Soc 45 (1983) 311-354
20. Wolfinger R., and O'Connell M. Generalized linear mixed models: a pseudo-likelihood approach. J Statist Comput Simul 4 (1993) 233-243
21. Peduzzi P., Concato J., Feinstein A.R., et al. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 48 (1995) 1503-1510
22. SAS Institute Inc. SAS/STAT user's guide. Version 6. 4th edn. Volume 1 (1989), SAS Institute Inc, Cary, NC
23. R Development Core Team (2007), R: a language and environment for statistical computing. http://www.R-project.org (accessed Nov 28, 2008).
24. Yao F.Y. Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria. Am J Transpl 8 (2008) 1982-1989
25. Volk M.L., Vijan S., and Marrero J.A. A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria. Am J Transpl 8 (2008) 839-846
26. Farazi P.A., and DePinho R.A. Hepatocellular carcinoma pathogenesis: from genes to environment. Nature Rev Cancer 6 (2006) 674-687
27. Hoshida Y., Villanueva A., Kobayashi M., et al. Gene expression in fixed tissue and outcome in hepatocellular carcinoma. N Engl J Med 359 (2008) 1-10
28. Zucman-Rossi J., Jeannot E., Nhieu J.T., et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43 (2006) 515-524
29. Grasso A., Stigliano R., Morisco F., et al. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study. Transplantation 81 (2006) 1532-1541
30. O'Malley M.E., Takayama Y., and Sherman M. Outcome of small (10-20 mm) arterial phase-enhancing nodules seen on triphasic liver CT in patients with cirrhosis or chronic liver disease. Am J Gastroenterol 100 (2005) 1523-1528
31. Shah S.A., Tan J.C.C., McGilvray I.D., et al. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. Transplantation 81 (2006) 1633-1639
32. Freeman R.B., Mithoefer A., Ruthazer R., et al. Optimizing staging for hepatocellular carcinoma before liver transplantation: a retrospective analysis of the UNOS/OPTN database. Liver Transpl 12 (2006) 1504-1511
33. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205-216
34. Majno P., Sarasin F., Mentha G., et al. Primary liver transplantation or primary liver resection and salvage liver transplantation for single small hepatocellular carcinoma in patients with cirrhosis. An outcome oriented decision analysis. Hepatology 31 (2000) 899-906
35. Wiesner R., Edwards E., Freeman R., et al. United Network for Organ Sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 33 (2003) 464-470
36. Freeman R.B., Edwards E.B., and Harper A.M. Waiting list removal rates among patients with chronic and malignant liver disease. Am J Transpl 6 (2006) 1416-1421
37. Sharma P., Harper A.M., Hernandez J.L., et al. Reduce priority MELD score for HCC does not adversely impact candidate survival awaiting liver transplantation. Am J Transpl 6 (2006) 1957-1962
38. Piscaglia F., Camaggi V., Ravaioli M., et al. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. Liver Transpl 13 (2007) 857-866
39. Duffy J.P., Vardanian A., Benjamin E., et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience in 467 patients at UCLA. Ann Surg 246 (2007) 502-511
40. Sugawara Y., Tamura S., and Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis 5 (2007) 310-312